Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;120(6):38-46.
doi: 10.1097/01.NAJ.0000668736.80609.4e.

CE: Opioid Use Disorder: Pathophysiology, Assessment, and Effective Interventions

Affiliations

CE: Opioid Use Disorder: Pathophysiology, Assessment, and Effective Interventions

Kate Garland Brown et al. Am J Nurs. 2020 Jun.

Abstract

Opioid use disorder (OUD) is a chronic, relapsing disease. Genetic variability, dysregulated stress system response, and history of opioid experimentation or escalating exposure all contribute to the likelihood of developing OUD, which produces complex brain changes that make it difficult to stop opioid use. Understanding the neurobiology of OUD helps nurses anticipate the behaviors of patients with OUD and approach them with empathy. Here, the authors discuss the pathophysiology of OUD, available screening tools, medical treatments, and behavioral interventions that have demonstrated efficacy in reducing substance use.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Effect of Opioids on the Brain
Figure 2.
Figure 2.
Effects of Opioids on the Stress Response

References

    1. Al-Hasani R, Bruchas M (2011) Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology, 115(6), 1363–1381. - PMC - PubMed
    1. Bendix J (2018). Opioid policy fallout. Medical Economics, 10, 96 Retrieved June 18, 2019 https://www.medicaleconomics.com/business/opioid-policy-fallout
    1. Blanco C, Volkow N (2019) Management of opioid use disorder in the USA:present status and future directions. The Lancet,393(10182), 1760–1772. - PubMed
    1. Burke BL, Arkowitz H, & Menchola M (2003). The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. Journal of Consulting on Clinical Psychology, 71, 843–862. - PubMed
    1. Butelman E, Chen C, Fry R, Kimani R, Levran O, Ott J, Correa R, Kreek M (2018) Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: gender specific features. Drug and Alcohol Dependence, 190, 179–87 - PubMed

Publication types

MeSH terms